Enanta Pharmaceuticals
ENTA
ENTA
107 hedge funds and large institutions have $114M invested in Enanta Pharmaceuticals in 2024 Q4 according to their latest regulatory filings, with 23 funds opening new positions, 35 increasing their positions, 31 reducing their positions, and 27 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding in top 10
Funds holding in top 10: →
less funds holding
Funds holding: →
less ownership
Funds ownership: →
15% less first-time investments, than exits
New positions opened: 23 | Existing positions closed: 27
21% less call options, than puts
Call options by funds: $56K | Put options by funds: $71K
48% less capital invested
Capital invested by funds: $220M → $114M (-$105M)
Holders
107
Holding in Top 10
1
Calls
$56K
Puts
$71K
Top Buyers
| 1 | +$5.97M | |
| 2 | +$3.56M | |
| 3 | +$1.91M | |
| 4 |
Millennium Management
New York
|
+$953K |
| 5 |
BlackRock
New York
|
+$801K |
Top Sellers
| 1 | -$10.4M | |
| 2 | -$8.14M | |
| 3 | -$4.03M | |
| 4 |
Citadel Advisors
Miami,
Florida
|
-$2.96M |
| 5 |
Ameriprise
Minneapolis,
Minnesota
|
-$1.48M |